These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34553608)

  • 1. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.
    Mahendru D; Jain A; Bansal S; Malik D; Dhir N; Sharma AR; Sarma P; Prakash A; Nahar U; Bhatia A; Bhattacharyya S; Medhi B
    Regen Med; 2021 Oct; 16(10):915-930. PubMed ID: 34553608
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
    Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
    Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating Parkinson's Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration.
    Mendes-Pinheiro B; Campos J; Marote A; Soares-Cunha C; Nickels SL; Monzel AS; Cibrão JR; Loureiro-Campos E; Serra SC; Barata-Antunes S; Duarte-Silva S; Pinto L; Schwamborn JC; Salgado AJ
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
    Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
    Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
    Vilaça-Faria H; Marote A; Lages I; Ribeiro C; Mendes-Pinheiro B; Domingues AV; Campos J; Lanceros-Mendez S; Salgado AJ; Teixeira FG
    Biochimie; 2021 Oct; 189():87-98. PubMed ID: 34182001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of uninduced and neuronally-induced human dental pulp stromal cells in a 6-OHDA model of Parkinson's disease.
    Azevedo EM; Fracaro L; Hochuli AHD; Ilkiw J; Bail EL; Lisboa MO; Rodrigues LS; Barchiki F; Correa A; Capriglione LGA; Brofman PRS; Lima MMS
    Cytotherapy; 2024 Sep; 26(9):1052-1061. PubMed ID: 38739074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
    Marques CR; Pereira-Sousa J; Teixeira FG; Sousa RA; Teixeira-Castro A; Salgado AJ
    Cytotherapy; 2021 Oct; 23(10):894-901. PubMed ID: 34059421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson's Disease.
    Cronin A; Grealy M
    Neuroscience; 2017 Dec; 367():34-46. PubMed ID: 29079063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells with Granulocyte Colony-Stimulating Factor Reduce Stress Oxidative Factors in Parkinson's Disease.
    Ghahari L; Safari M; Rahimi Jaberi K; Jafari B; Safari K; Madadian M
    Iran Biomed J; 2020 Mar; 24(2):89-98. PubMed ID: 31677610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Ni W; Zhou J; Ling Y; Lu X; Niu D; Zeng Y; Qiu Y; Si Y; Wang J; Zhang W; Wang Z; Hu J
    Brain Res; 2022 Sep; 1790():147978. PubMed ID: 35690143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.
    Cova L; Bossolasco P; Armentero MT; Diana V; Zennaro E; Mellone M; Calzarossa C; Cerri S; Deliliers GL; Polli E; Blandini F; Silani V
    Apoptosis; 2012 Mar; 17(3):289-304. PubMed ID: 22160861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: Potential therapeutic strategy in Parkinson's disease.
    Bonilla-Porras AR; Arevalo-Arbelaez A; Alzate-Restrepo JF; Velez-Pardo C; Jimenez-Del-Rio M
    Cytotherapy; 2018 Jan; 20(1):45-61. PubMed ID: 29079356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.